alexa Ventricular Hypertrophy Impact Factor|omicsgroup|journal Of Vascular Medicaine And Surgery

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Ventricular Hypertrophy Impact Factor

It is clinical condition which is characterized by thickening of ventricular walls in the heart. Mostly left ventricular hypertrophy is common. Common cause of ventricular hypertrophy is hypertension, aortic valve stenosis, Hypertrophic cardiomyopathy and Athletic training. It can be manged by using ACE inhibitors, Angiotensin II receptor blockers, Thiazide diuretics, Beta blockers and Calcium channel blockers.The impact factor of journal provides quantitative assessment tool for grading, evaluating, sorting and comparing journals of similar kind. It reflects the average number of citations to recent articles published in science and social science journals in a particular year or period, and is frequently used as a proxy for the relative importance of a journal within its field. It is first devised by Eugene Garfield, the founder of the Institute for Scientific Information.The impact factor of a journal is evaluated by dividing the number of current year citations to the source items published in that journal during the previous two years.
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on September, 2020